Trial site
Marseille
- 14running trials
- 9closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Familial hypercholesterolaemia4 trials
- Childhood cancers3 trials
- Metastatic breast cancer3 trials
- Chronic myeloid leukaemia2 trials
- Colorectal cancer2 trials
- Coronary artery disease2 trials
- Lung cancer2 trials
- Prostate cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Aortic stenosis1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- and 7 more
- Phase
- Phase 39 trials
- Phase 1/23 trials
- Phase 23 trials
- Phase 12 trials
- Phase 2/32 trials
- Phase 41 trial
- Status
- Active, not recruiting8 trials
- Completed7 trials
- Recruiting6 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals23 trials
Running trials
Recruiting
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Recruiting
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Aortic stenosis1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Heart failure1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Terminated
Completed
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
Completed
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026